Delivery Order SPE2DB25D3306-SPE2DB26FUAQL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $43,600.80 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with a completion date of July 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems....
- The Defense Logistics Agency awarded a $34,669.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of July 24, 2025. This competitively awarded contract, issued on July 23, 2025, carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $35,801.16 delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of October 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $28,856.00 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits. The contract is firm fixed price with no set-aside designation and was competitively awarded. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The work will be performed in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,266.27 by the Defense Logistics Agency on August 12, 2025, for the supply of Betaseron 0.3 mg kits. This firm fixed-price delivery order, which carries an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $22,385.72 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits under a firm fixed price contract. This competitively awarded, non-set-aside delivery order was executed on September 9, 2025, with an ultimate completion date of September 10, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $11,859.47 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 25, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs....
- The Defense Logistics Agency awarded a $31,415.33 delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with a completion date of October 30, 2025. This firm fixed price contract, awarded on October 29, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, will supply this interferon beta-1b...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on September 12, 2025, for the supply of Betaseron 0.3 mg kits valued at $16,778.88. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's pharmaceutical supply relationship with DLA, which procures medical supplies...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $35,674.09 by the Defense Logistics Agency for the supply of Betaseron 0.3 mg kits, with a completion date of September 30, 2025. This firm fixed-price delivery order, awarded on September 29, 2025, represents a competitively awarded contract with no set-aside designation. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB26FUAQLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $45,542.34 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical needs, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This Betaseron delivery order reflects the company's ongoing role in supporting Defense Health Agency medical supply requirements through flexible, competitively awarded contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.5k | 11/10/25 |